Search
Welcome to Saul Ewing’s Public Companies Quarterly Update series. Our intent is to, on a quarterly basis, highlight important legal developments of which we think public companies should be aware. This edition is related to developments during the second quarter of 2023. If you would like to discuss...
BOSTON, MA (February 7, 2023) – Jon Barooshian and Patrick Tracey bring a combined five decades of experience as litigators to their new roles as partners in the firm’s Boston office. Mr. Barooshian will focus his practice on white collar and government enforcement matters and tax controversies...
Evolution of Cyber Insurance and the Impact on Cyber and Privacy Risk Management Laurie Kamaiko will speak at the Privacy + Security Forum 2022. Her panel is entitled "Evolution of Cyber Insurance and The Impact on Cyber and Privacy Risk Management." More details to come.
Saul Ewing is a proud sponsor of the M&A East Conference held by the Philadelphia Chapter of the Association of Corporate Growth. M&A East attracts top strategic and financial dealmakers as well as leading middle market advisors and provides an environment for valuable networking. The conference...
THE CLASS ACTION MECHANISM, RISKS, AND STRATEGIES TO PROTECT YOUR COMPANY Jon Singer, a Partner in the Firm's Class Actions Practice, will be speaking during the Association of Corporate Counsel's July New to In-House Update. This session will provide a high level overview intended to educate new in...
Saul Ewing LLP represented Genesis Unicorn Capital, LLC, in its acquisition of and role as the sole sponsor for Genesis Unicorn Capital Corp. a special purpose acquisition company (SPAC), in the SPAC's $75 Million initial public offering (IPO) of 7,500,000 units at a price of $10.00 per unit. The...
Saul Ewing LLP represented Signal Hill Acquisition Corp., a special purpose acquisition company, in its initial public offering of 10,000,000 units at a price of $10.00 per unit, resulting in gross proceeds of $100,000,000. The units are listed on The Nasdaq Global Market (Nasdaq) and began trading...
Washington, D.C., November 24, 2021 – Saul Ewing LLP served as counsel to Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) in the successful completion today of its previously announced $450 million acquisition of Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS). The acquisition strengthens Supernus'...
Saul Ewing securities attorneys Justin B. Ettelson, Michael A. Gold, Mark I. Gruhin, Andrew F. Barris and Jourdan S. Garvey have co-edited the 2021 edition of SEC Reporting Rules books.* For those responsible for filing reports with the SEC for public companies, the 2021 SEC Reporting Rules books...